Michael Wolf

28.8k citations
188 papers · 19.9k indexed · 10 hit papers · h-index 50
  • Oncology top 0.1%
    • Colorectal Cancer Treatments and Studies 19
  • Finance top 0.1%
    • Financial Risk and Volatility Modeling 30
    • Financial Markets and Investment Strategies 17
    • Statistical Methods and Inference 31
    • Statistical Methods in Clinical Trials 28
    • Statistical Methods and Bayesian Inference 22
    • Advanced Statistical Methods and Models 15
    • Lung Cancer Treatments and Mutations 17
  • Hepatology top 0.5%

Michael Wolf

182 papers receiving 19.1k citations

Hit Papers

Randomized, Phase III Trial of Panitumumab With Inf...1.4k199920262008201750010001.5k2.0k

Peers

Michael Wolf
Comparison fields: 5 of 200
  • Oncology 9.6k
  • Finance 3.4k
  • Statistics and Probability 2.1k
  • Pulmonary and Respiratory Medicine 6.8k
  • Hepatology 1.1k
Replace Peter A. Hall with:
Peter A. Hall United Kingdom
Jun S. Liu United States
John D. Kalbfleisch United States
Wing Hung Wong United States
Jeremy M. G. Taylor United States
Dongsheng Tu Canada
Mike West United States
Donald A. Berry United States
Murray Aitkin United Kingdom
Peter Ellis United Kingdom
Michael Wolf relative to Peter A. Hall United Kingdom Peter A. Hall's profile →
Citations per field
00.5×3.9×
Peter A. Hall · 1×
Citations per year

Countries citing papers authored by Michael Wolf

Since Specialization
Citations

This map shows the geographic impact of Michael Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wolf more than expected).

Fields of papers citing papers by Michael Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wolf. The network helps show where Michael Wolf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Wolf Line = papers co-authored together Michael Wolf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20240
3 20230
4 20195
5 201927
6 20149
7 20131
8 201216
9 201210
10
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Studybreakdown →
20101351
11 20101
12
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancerbreakdown →
20082400
13 200765
14
Integrated DNA/RNA microarray profiling of hormone-refractory clinical prostate cancers and metastases indicates deregulation of several pathways, including androgen/AR, Hedgehog, MAPK and neuroactive ligand/receptor signalling
20061
15
A well-conditioned estimator for large-dimensional covariance matricesbreakdown →
20031726
16 200055
17 199619
18 19966
19 19954
20 19926

About Michael Wolf

Michael Wolf is a scholar working on Statistics and Probability, Finance, Management Science and Operations Research, General Decision Sciences and Oncology, having authored 188 papers that have together received 19.9k indexed citations. Recurring topics across this work include Statistical Methods and Inference (31 papers), Financial Risk and Volatility Modeling (30 papers), Statistical Methods in Clinical Trials (28 papers), Statistical Methods and Bayesian Inference (22 papers), Colorectal Cancer Treatments and Studies (19 papers), Financial Markets and Investment Strategies (17 papers), Lung Cancer Treatments and Mutations (17 papers) and Advanced Statistical Methods and Models (15 papers). The work is most often cited by research in Oncology (9.6k citations), Finance (3.4k citations), Statistics and Probability (2.1k citations), Pulmonary and Respiratory Medicine (6.8k citations) and Hepatology (1.1k citations). Michael Wolf has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Olivier Ledoit, Joseph P. Romano, Salvatore Siena, Marc Peeters, Eric Van Cutsem, Rafael G. Amado, Roy S. Herbst, Steven D. Averbuch, Ronald B. Natale and Joan H. Schiller. Their work appears in journals such as Journal of Clinical Oncology, The Annals of Statistics, Investigational New Drugs, Lung Cancer and Journal of Econometrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026